MAPT and Alzheimer disease: Due to the close relationship between extracellular Tau and AD, Tau-binding agents that can access extracellular Tau, such as anti-Tau antibodies, might be valuable tools for preventing the uptake of extracellular Tau into neurons and decreasing the spread of Tau pathology.